Likert scale for practitioners in our questionnaire
Conditions
Interventions
Group 1: This is an anonymous online questionnaire study targeting mental health professionals with experience in psychedelic-assisted therapy. It aims to explore expert opinions on patient and therap
Sponsors
Charité – Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Practitioner with experience in psychedelic-assisted therapy
Exclusion criteria
Exclusion criteria: Practitioner without experience in psychedelic-assisted therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| There is no formal clinical endpoint, as this is not an interventional study involving dosing sessions with psychedelic substances. Instead, this is a questionnaire-based study directed at mental health professionals with experience in psychedelic-assisted therapy. The aim is to gather expert clinical perspectives on factors that may influence therapeutic response to psychedelic-assisted therapy in the treatment of psychiatric disorders. Data is collected through a structured, anonymous online questionnaire. | — |
Countries
Germany
Contacts
Public ContactFelix Betzler
Charité – Universitätsmedizin Berlin
Outcome results
None listed